Reports for TEVA-FINASTERIDE
Brand name
TEVA-FINASTERIDE
Company Name
TEVA CANADA LIMITED
|
Drug Identification Number
02348500 |
Ingredients
FINASTERIDE |
Ingredient Strength
5 MG |
ATC Code
G04CB |
ATC Descriptor
DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY |
Status
MARKETED
|
Shortage reports
| Brand name | Packaging Size | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|
| TEVA-FINASTERIDE | 100 | Resolved | 2017-08-21 | 2017-10-10 | 19944 |
| TEVA-FINASTERIDE | 100 | Resolved | 2020-05-01 | 2020-05-29 | 113785 |
| TEVA-FINASTERIDE | 100 | Resolved | 2021-09-30 | 2021-10-07 | 146459 |
| TEVA-FINASTERIDE | 100 | Resolved | 2023-02-09 | 2023-04-28 | 184210 |
| TEVA-FINASTERIDE | 100 | Actual shortage | 2025-11-20 | 2025-11-20 | 272307 |
Showing 1 to 5 of 5
Discontinuation reports
| Brand name | Packaging Size | Status | Date Created | Date Updated | Reports |
|---|
Showing 1 to 0 of 0